Pharmacological approaches in celiac disease

Area of Science:

• Immunology
• Gastroenterology
• Autoimmune diseases

Background:

• Celiac disease is an autoimmune enteropathy triggered by gluten ingestion.
• It involves immune responses to gluten and transglutaminase 2.
• The only current treatment is a strict gluten-free diet.

Purpose of the Study:

• To explore novel therapeutic strategies for celiac disease.
• To review emerging treatments targeting gluten, immune responses, and gut barrier function.
• To discuss therapies that manage symptoms or complement the gluten-free diet.

Main Methods:

• Review of current and developing celiac disease therapies.
• Categorization of therapies based on their mechanism of action (e.g., immune modulation, gluten detoxification, barrier enhancement).
• Inclusion of examples such as vaccines, enzyme therapies, and microbial interventions.

Main Results:

• Multiple therapeutic avenues are under investigation.
• Approaches target gluten breakdown, immune system regulation, and intestinal permeability.
• Emerging treatments include vaccines, enzyme therapies, and microbiome modulation.

Conclusions:

• A range of promising therapies are in development for celiac disease.
• These therapies aim to provide alternatives or adjuncts to the gluten-free diet.
• Future treatments may offer improved management and quality of life for patients.